Last reviewed · How we verify

NCT05352373

The Role of Dietary Calcium for the Treatment of Osteopenia in Girls With Rett Syndrome

Completed NA Last updated 28 April 2022
What this trial tests

NA trial testing calcium in Rett Syndrome in 32 participants. Completed in 1 March 2012.

Timeline
1 March 2008
Primary endpoint
1 March 2012
1 March 2012

Quick facts

Lead sponsorBaylor College of Medicine
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment32
Start date1 March 2008
Primary completion1 March 2012
Estimated completion1 March 2012

Drugs / interventions tested

Conditions studied

Sponsor

Baylor College of Medicine

Who can join

Adults 5 to 30, female only, with Rett Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized, placebo-controlled trial of oral calcium supplementation for osteopenia in girls and women with Rett syndrome

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Diet and Nutrients in Rare Neurological Disorders: Biological, Biochemical, and Pathophysiological Evidence.
    Briglia M, Allia F, Avola R, Signorini C, et al · · 2024 · cited 3× · PMID 39339713 · DOI 10.3390/nu16183114

Verify or expand the search:

Other trials of calcium

Trials testing the same drug.

Other recruiting trials for Rett Syndrome

Currently open trials in the same condition.

Other Baylor College of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05352373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing